Objectives:

1.  Understand state of art treatment of sickle cell disease symptomology

2.  Effective use of hydroxyurea for reduction of vaso-occlusive crises

3.  Role of transplantation for cure of sickle cell disease

Session date: 
02/09/2017 - 8:30am to 9:00am CST
Location: 
Little Company of Mary Hospital
Evergreen Park, IL 60805
United States
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation

Please login or create an account to proceed.
Speaker Name: 
John Cunningham, MD MRCP